Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Bortezomib-Based Regimens and...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Bortezomib-Based Regimens and Plasma Cell Leukemia

Bortezomib-Based Regimens and Plasma Cell Leukemia

Bibliographic Details
Main Author: Ali Zahit Bolaman
Format: Article
Language:English
Published: Galenos Publishing House 2021-02-01
Series:Turkish Journal of Hematology
Subjects:
bortezomib
plasma cell leukemia
treatment
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-16945
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1308-5263

Similar Items

  • Successful treatment with bortezomib-containing regimen of primary plasma cell leukemia: a case report
    by: Mohammad Bader Obeidat, et al.
    Published: (2020-05-01)
  • Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study
    by: Huijuan Wang, et al.
    Published: (2020-05-01)
  • Immunoglobulin D multiple myeloma, plasma cell leukemia and chronic myelogenous leukemia in a single patient treated simultaneously with lenalidomide, bortezomib, dexamethasone and imatinib
    by: Naveed Ali, et al.
    Published: (2016-03-01)
  • Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia
    by: Ingrid M. Wirth, et al.
    Published: (2020-01-01)
  • Evaluation of the combined effects of doxorubicin and bortezomib on the human acute lymphoblastic leukemia cell line
    by: Korga Agnieszka, et al.
    Published: (2019-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs